Breaking News

The Galien Basis Pronounces 2022 Prix Galien USA Nominees in “Easiest Biotechnology Product,” “Easiest Pharmaceutical Agent” and “Easiest Clinical Era”

The Galien Basis Pronounces 2022 Prix Galien USA Nominees in “Easiest Biotechnology Product,” “Easiest Pharmaceutical Agent” and “Easiest Clinical Era”

— Winners to be Identified by way of Committee of Prominent Clinical Leaders on October 27, 2022, on the Prix Galien USA Awards Rite in New York Town

NEW YORK, July 26, 2022 /PRNewswire/ — The Galien Basis, the premier international establishment devoted to honoring innovators in existence sciences, as of late introduced the 2022 Prix Galien USA Award nominees for “Easiest Biotechnology Product,” “Easiest Pharmaceutical Agent,” and “Easiest Clinical Era.” Winners shall be introduced right through the Prix Galien USA Awards Rite on October 27, 2022, on the American Museum of Herbal Historical past in New York Town.

“Once a year, comparing and spotting the superb submissions that come via for the Prix Galien Awards is among the biggest honors,” stated Dr. Sue Desmond-Hellmann, Chair of the Prix Galien USA and Prix Galien Global Award Committees and previous CEO of the Invoice & Melinda Gates Basis. “The dedication and willpower of the innovators who expand those merchandise by no means stop to amaze the awards committee, and we’re excited to announce the 2022 nominations.”

The 2022 Prix Galien USA nominees come with merchandise evaluated within the following classes: “Easiest Biotechnology Product” – 22 nominees; “Easiest Pharmaceutical Agent” – 33 nominees; and “Easiest Clinical Era” – 24 nominees.

To qualify, each and every candidate should be U.S. Meals and Drug Management (FDA) authorized for advertising and marketing throughout the remaining 5 years and display super doable to beef up human well being. Gross sales knowledge aren’t regarded as by way of the nominating committee of their award nominee variety, most effective science and well being have an effect on.

Easiest Biotechnology Product (Nominees)

Albireo Pharma, Inc.

Bylvay®

Alnylam Prescription drugs

GIVLAARI®

Alnylam Prescription drugs

OXLUMO®

Amgen Inc.

EVENITY® (romosozumab-aqqg)

argenx

VYVGART®

AstraZeneca & Daiichi Sankyo Co.

ENHERTU®

BeiGene

Brukinsa®

Bristol Myers Squibb

Abecma (idecabtagene vicleucel)

ChemoCentryx, Inc.

TAVNEOS® (avacopan)

Genentech, a member of the Roche Workforce

Polivy®

GSK

BLENREP® (belantamab mafodotin-blmf)

Horizon Therapeutics

TEPEZZA® (teprotumumab-trbw)

Jazz Prescription drugs

Rylaze®

Merck & Co., Inc

VAXNEUVANCE

Novartis Gene Treatments

Zolgensma® (onasemnogene abeparvovec-xioi)

Pfizer Inc.

PREVNAR 20™

Regeneron Prescription drugs, Inc.

Evkeeza®

Regeneron Prescription drugs, Inc.

Inmazeb™ (atoltivimab, maftivimab, and odesivimab-ebgn)

Regeneron Prescription drugs, Inc. and Sanofi

Dupixent® (dupilumab)

Sanofi

Cablivi®

VBI Vaccines Inc.

PreHevbrio™

XVIVO Perfusion

XPS with STEEN Answer

Easiest Pharmaceutical Agent (Nominees)

AbbVie Inc.

RINVOQ®

Alkermes, Inc

LYBALVI®

Amgen Inc.

LUMAKRAS®

Astellas Pharma Inc.

XOSPATA®

Aurinia Prescription drugs Inc.

LUPKYNIS®

Biohaven Prescription drugs

Nurtec® ODT

Blueprint Drugs

AYVAKIT™ (avapritinib)

Blueprint Drugs

GAVRETO® (pralsetinib)

Deciphera Prescription drugs

QINLOCK®

Dr. Reddy’s Laboratories, Inc.

ELYXYB™

Eiger BioPharmaceuticals, Inc.

ZOKINVY®

Eli Lilly and Corporate

Olumiant®

Epizyme Inc.

TAZVERIK®

Genentech, a member of the Roche Workforce

Rozlytrek

Gilead Sciences, Inc.

VEKLURY® (remdesivir)

Incyte Corp.

Pemazyre® (pemigatinib)

Ironshore Prescription drugs Inc.

JORNAY PM®

Janssen

RYBREVANT®

Karyopharm Therapeutics Inc.

XPOVIO®

Mayne Pharma

Nextstellis® (drospirenone and estetrol drugs) 3 mg/14.2 mg

Merck & Co., Inc

VERQUVO®

Merck & Co., Inc

WELIREG

Mirum Prescription drugs, Inc.

LIVMARLI® (maralixibat) oral answer

Myovant Sciences, Inc.

Myfembree®

Myovant Sciences, Inc.

ORGOVYX™ (relugolix)

Novartis Prescription drugs Company

Adakveo®

Novartis Prescription drugs Company

PIQRAY®

Pfizer Inc.

Braftovi® Mektovi®

Pfizer Inc.

Cibinqo®

Seagen Inc.

TUKYSA® (tucatinib)

Servier Prescription drugs

ASPARLAS®

Servier Prescription drugs

TIBSOVO®

ViiV Healthcare

Apretude (cabotegravir extended-release injectable suspension)

Easiest Clinical Era (Nominees)

Alcon

AcrySof™ IQ Vivity™ Prolonged Imaginative and prescient Intraocular Lens (IOL)

Bausch + Lomb

XIPERE®

Boston Clinical | Baylis Clinical

VersaCross Transseptal Platform

BD

PureWick™ Feminine Exterior Catheter / PureWick Urine Assortment Device

BD

Venovo™ Venous Stent Device

Boston Clinical

ELUVIA™ Drug-Eluting Vascular Stent Device

Boston Clinical

SpaceOAR VUE™ Hydrogel

Cala Well being

Cala Trio™

CVRx®

Barostim™

Edwards Lifesciences

Edwards SAPIEN 3 Transcatheter Pulmonary Valve Device with Alterra Adaptive Prestent

Flosonics Clinical Inc.

FloPatch (catalog #FP120)

GT Clinical Applied sciences, Inc.

GammaTile®

Guardant Well being

Guardant360 CDx

Impel Prescription drugs Inc.

Trudhesa®

Lantheus

PYLARIFY® injection and PYLARIFY AI™

LifeVac

LifeVac, LLC

Natera, Inc.

Prospera

Natera, Inc.

Signatera

Olympus The united states Inc.

BF-UC190F Endobronchial Ultrasound (EBUS) Bronchoscope

Organon

The Jada® Device

Outset Clinical, Inc.

Tablo® Hemodialysis Device

Usual Bariatrics, Inc.

Titan SGS®

True Virtual Surgical procedure

Occipta™

Visby Clinical, Inc.

Visby Clinical Sexual Well being Click on Check

“I’m thankful the Prix Galien Awards give you the alternative to acknowledge excellence in biopharmaceutical and clinical era inventions that beef up the human situation,” stated Bruno Cohen, Chairman of The Galien Basis. “We look ahead to showing those nominees and all in their accomplishments on heart degree right through an exquisite birthday celebration.”

The Prix Galien USA Awards Committee consists of 10 famend leaders from the biomedical trade and academia, together with two Nobel Laureates, chargeable for comparing nominees.

Prix Galien Awards Committee 2022

Sue DESMOND-HELLMANN
M.D., M.P.H., Former Leader Govt Officer, Invoice & Melinda Gates Basis
Committee Chair

Richard AXEL
M.D., Nobel Laureate, Co-director, The Kavli Institute for Mind Science; Professor, Columbia College Clinical Heart

Linda BUCK
Ph.D., Nobel Laureate, Fred Hutchinson Most cancers Analysis Heart member; Professor of Body structure and Biophysics, College of Washington

Laurie GLIMCHER
M.D., President and CEO, Dana Farber Most cancers Institute, Professor of Medication, Harvard Clinical College

Mary-Claire KING
Ph.D., American Most cancers Society Professor of Genome Sciences and Clinical Genetics, College of Washington

Robert S. LANGER
M.D., David H. Koch Institute Professor, Massachusetts Institute of Era

Cato T. LAURENCIN
M.D., Ph.D. College Professor, College of Connecticut

Steven J. LESTER
M.D., Leader Clinical Officer, Mayo Hospital-ASU MedTech Accelerator

Michael ROSENBLATT
M.D., Leader Clinical Officer, Flagship Pioneering

Marc TESSIER-LAVIGNE
Ph.D., President, Stanford College

Elie WIESEL
Nobel Peace Prize Laureate, Boston College, Honorary Founding President, In Memoriam

In regards to the Galien Basis

The Galien Basis fosters, acknowledges and rewards excellence in medical innovation to beef up the state of human well being. Our imaginative and prescient is to be the catalyst for the improvement of the following era of leading edge therapies and applied sciences that can have an effect on the state of clinical follow and save lives.

The Basis oversees and directs actions in america for the Prix Galien, a world awards program devoted to growth via leading edge medications building, with chapters in 14 international locations and Africa. The Prix Galien was once created in 1970 by way of Roland Mehl in honor of Galien, the daddy of clinical science and fashionable pharmacology. International, the Prix Galien is considered the an identical of the Nobel Prize in biopharmaceutical analysis.

For more info, consult with www.galienfoundation.org.

Apply the Basis on social media: https://www.fb.com/GalienFoundation/ 
https://twitter.com/GalienFdn
https://www.linkedin.com/corporate/the-galien-foundation/

Media Touch:
Kara Bradley
Finn Companions [email protected]
646-213-7243

SOURCE The Galien Basis